Effects of type 2 diabetes on brain structure and cognitive function: African American-diabetes heart study MIND

American Journal of Neuroradiology

Volumn 36, Issue 9, 2015, Pages 1648-1653

  Whitlow, C T ^a,b,c   Sink, K M ^d   Divers, J ^e   Smith, S C ^c   Xu, J ^c   Palmer, N D ^c,f   Hugenschmidt, C E ^d   Williamson, J D ^d   Bowden, D W ^c,f   Freedman, B I ^f,g   Maldjian, J A ^a,b,c  

^a Section of Neuroradiology   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c Department of Biomedical Engineering ^*  (United States)

^d Section on Internal Medicine and Gerontology Bowman Gray   (United States)

^e Division of Public Health Sciences   (United States)

^f Center for Genomics and Personalized Medicine Research   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ANXIETY ASSESSMENT; ANXIETY BRIEF SYMPTOM INVENTORY; ARTICLE; BRAIN FUNCTION; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COGNITION; DIABETIC MICROANGIOPATHY; DIET RESTRICTION; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RADIOLOGICAL PARAMETERS; REY AUDITORY VERBAL LEARNING TEST; STROOP TEST; WECHSLER ADULT INTELLIGENCE SCALE; WHITE MATTER LESION; WORKING MEMORY; ATROPHY; BRAIN; COMPLICATION; PATHOLOGY; PROCEDURES;

AFRICAN AMERICANS; ATROPHY; BRAIN; COGNITION; DIABETES MELLITUS, TYPE 2; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84941354939     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A4321     Document Type: Article

References (44)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
2. Simic I, Pecin I, Tedeschi-Reiner E, et al. Risk factors for microvascular atherosclerotic changes in patients with type 2 diabetes mellitus. Coll Antropol 2013;37:783-87
3. Biessels GJ. Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms. Neth J Med 1999;54:35-45
4. van Harten B, de Leeuw FE, Weinstein HC, et al. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006;29:2539-48
5. van Elderen SG, de Roos A, de Craen AJ, et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year followup. Neurology 2010;75:997-1002
6. Moran C, Phan TG, Chen J, et al. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013;36:4036-42
7. Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 2013;35:152-60
8. Ryan JP, Fine DF, Rosano C. Type 2 diabetes and cognitive impairment: contributions from neuroimaging. J Geriatr Psychiatry Neurol 2014;27:47-55
9. Sato N, Morishita R. Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short-and long-term modification by non-genetic risk factors. Front Aging Neurosci 2013;5:64
10. Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev 2007;64 (5 suppl):101S-56S
11. Divers J, Hugenschmidt C, Sink KM, et al. Cerebral white matter hyperintensity in African Americans and European Americans with type 2 diabetes. J Stroke Cerebrovasc Dis 2013;22:e46-52
12. Thabit H, Kyaw Tun T, McDermott J, et al. Executive function and diabetes mellitus: a stone left unturned? Curr Diabetes Rev 2012;8:109-15
13. Qiu C, Sigurdsson S, Zhang Q, et al. Diabetes, markers of brain pathology, and cognitive cognition: the age, gene/environment susceptibility- Reykjavik study. Ann Neurol 2014;75:138-46
14. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry 1987;48:314-18
15. Grace J, Nadler JD, White DA, et al. Folstein vs modified Mini-Mental State Examination in geriatric stroke: stability, validity, and screening utility. Arch Neurol 1995;52:477-84
16. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-99
17. Strauss E, Sherman S, Spreen O. A Compendium of Neuropsychological 661 Tests: Administration, Norms, and Commentary. 3rd ed. New York: Oxford University Press; 2006
18. Duff K, Schoenberg MR, Scott JG, et al. The relationship between executive functioning and verbal and visual learning and memory. Arch Clin Neuropsychol 2005;20:111-22
19. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio: Psychological Corp; 1997
20. Hoyer WJ, Stawski RS, Wasylyshyn C, et al. Adult age and digit symbol substitution performance: a meta-analysis. Psychol Aging 2004;19:211-14
21. Rosano C, Simonsick EM, Harris TB, et al. Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology 2005;24:8-14
22. MacLeod CM. Half a century of research on the Stroop effect: an integrative review. Psychol Bull 1991;109:163-203
23. Houx PJ, Jolles J, Vreeling FW. Stroop interference: aging effects assessed with the Stroop Color-Word Test. Exp Aging Res 1993;19:209-24
24. Klein M, Ponds RW, Houx PJ, et al. Effect of test duration on agerelated differences in Stroop interference. J Clin Exp Neuropsychol 1997;19:77-82
25. Van der Elst W, Molenberghs G, Van Boxtel MP, et al. Establishing normative data for repeated cognitive assessment: a comparison of different statistical methods. Behav Res Methods 2013;45:1073-86
26. Reis JP, Launer LJ, Terry JG, et al. Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: the CARDIA study. Atherosclerosis 2013;231:72-77
27. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401
28. Gilbar O, Ben-Zur H. Adult Israeli community norms for the Brief Symptom Inventory (BSI). Int J Stress Manage 2002;9:1-10
29. Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage 2000;11:805-21
30. Schmidt P, Gaser C, Arsic M, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. Neuroimage 2012;59:3774-83
31. Maldjian JA, Whitlow CT, Saha BN, et al. Automated white matter total lesion volume segmentation in diabetes. AJNR Am J Neuroradiol 2013;34:2265-70
32. Jovicich J, Czanner S, Han X, et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage 2009;46:177-92
33. Han X, Jovicich J, Salat D, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 2006; 32:180-94
34. Aggarwal NT, Wilson RS, Bienias JL, et al. The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol 2010;67:475-82
35. Brickman AM, Schupf N, Manly JJ, et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol 2008;65:1053-61
36. Kumar R, Anstey KJ, Cherbuin N, et al. Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60-to 64-year-old community sample. Am J Geriatr Psychiatry 2008;16:989-98
37. Biessels GJ, Koffeman A, Scheltens P. Diabetes and cognitive impairment: clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol 2006;253:477-82
38. Schmidt R, Launer LJ, Nilsson LG, et al. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) study. Diabetes 2004;53:687-92
39. Manschot SM, Biessels GJ, de Valk H, et al. Metabolic and vascular determinants of impaired cognitive performance and abnormali-ties on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007;50:2388-97
40. Kumar A, Haroon E, Darwin C, et al. Gray matter prefrontal changes in type 2 diabetes detected using MRI. J Magn Reson Imaging 2008;27:14-19
41. de Bresser J, Tiehuis AM, van den Berg E, et al. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 2010;33:1309-14
42. Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74
43. Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008;7:184-90
44. Kloppenborg RP, van den Berg E, Kappelle LJ, et al. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol 2008;585:97-108